SOUTH AVENUE WOMEN’S SERVICES
ROCHESTER, NY 14620
(585) 271-3850

Medication Guide
MIFEPREX TM (mif-eh-prex) RU486

Mifeprex is a FDA approved medication used to end early pregnancies. Early pregnancy is defined as 63 days (9 weeks) or less since your last menstrual period. Alternatively, you may continue the pregnancy or you may elect to undergo a minor surgical procedure called a suction curettage.

Mifeprex blocks a hormone needed for a pregnancy to continue. It is very effective in ending early pregnancy when combined with a second medication called misoprostol. If you take these medications and fail to abort the pregnancy a suction procedure is strongly advised because these medications may cause birth defects.

On your first visit we will take your history and perform a physical exam including a trans-vaginal ultrasound. We will also need your blood RH typed so if you have not provided us with it you will have blood drawn at your expense. After you have read the consent forms you will meet with an educator who will explain the process and answer all your questions. After you have time to ask questions and sign the consent form you will then take by mouth the MIFEPREX (1 tablet/200 mg). Occasional side effects include diarrhea, nausea, vomiting, headache, back pain and dizziness.

You will receive 4 (200 mcg) tablets of misoprostol to insert VAGINALLY in 24 to 48 hours. You may experience cramping and bleeding for the next several hours. We recommend you insert at a time you can rest for about 10 hours. Drink several glasses of water and get up from a lying position slowly to avoid getting dizzy. A prescription for pain medication will be given to you. Avoid Advil/Motrin/Ibuprofen during this process. Plan to use the misoprostol at a time when you can be home and lie down. Some women may experience vaginal bleeding prior to the insertion of the misoprostol. This does not mean the abortion is complete. You will still need to insert the misoprostol because this is what completes the process. If you have any questions please call the office during office hours (9am-4pm). Your bleeding may be similar to or greater than a heavy period. You may see blood clots, a small sac or tissue that comes from the uterus. THIS IS AN EXPECTED PART OF ENDING THE PREGNANCY. Bleeding and spotting can last up to 30 days the average time is 9 to 16 days.

Sexual intercourse, tampons and tub baths are not recommended for two weeks after swallowing the Mifeprex.

YOU MUST CALL OUR OFFICE AT (585) 271-3850 AT ANY TIME IF YOU EXPERIENCE EXCESSIVE BLEEDING DEFINED AS SOAKING THROUGH TWO THICK FULL SIZE SANITARY PADS PER HOUR FOR TWO CONSECUTIVE HOURS OR IF YOU SPIKE A TEMPERATURE OF 101 DEGREES OR HIGHER OR IF YOU EXPERIENCE EXCESSIVE DIARRHEA.

You must return to our office within 1-2 weeks to be sure that the pregnancy has ended. Another trans-vaginal ultrasound will be performed at this time. Birth control options will be discussed at this visit.

MIFEPREX TM (Mifepristone) Tablets, 200 mg
PATIENT CONSENT
MIFEPREX* (Mifepristone) Tablets

1. I have read the attached Medication Guide for using Mifeprex and misoprostol to end my pregnancy.

2. I discussed the information with the health care provider.

3. The provider answered all any questions and told me about the risks and benefits of using Mifeprex and misoprostol to end my pregnancy including but not limited to those stated on the medication guide.

4. I believe I am no more than 63 days (9) weeks pregnant.

5. I understand that I will take one table of Mifeprex by mouth in my provider’s office (1 Tablet/200 mg). Side effects include nausea, vomiting, vaginal spotting or bleeding.

6. I understand that I will insert misoprostol (4-tablets/200 mg) in my vagina at home 24-48 hours after I take Mifeprex. I understand I will experience vaginal bleeding and cramping after inserting the misoprostol. Other side effects include diarrhea, nausea, vomiting, dizziness and fatigue.

7. My provider gave me advice on what to do if I develop heavy bleeding (bleeding 2 pads/hour) or need emergency care due to the treatment.

8. Bleeding and cramping do not mean that my pregnancy has ended. Therefore, I must return to my provider’s office within 1-2 weeks (no later than 14 days) after I take Mifeprex to be sure that my pregnancy has ended and that I am well.

9. I know that in some cases, the treatment will not work and the pregnancy will continue. This happens in about 1 out of 300 women who attempt medical abortions.

10. I understand that there is a chance that there my be birth defects if my pregnancy continues after treatment with Mifeprex and/or misoprostol. I will talk to my provider about my option which may include a surgical procedure.

11. I understand that if the medicines I take do not end my pregnancy and I decide to have a surgical procedure to end my pregnancy or if I need a surgical procedure to stop my bleeding, my provider will do that procedure or refer me to another provider.

12. I have my provider’s name, address and phone number and I know I can call if I have any questions or concerns.

13. I have decided to take Mifeprex and misoprostol to end my pregnancy and will follow my provider’s advice about when to take each drug and what to do in an emergency.

14. It is mandatory to return to South Avenue Women’s Services for a follow up visit and ultrasound after using RU486 between 2 and 14 days. If you are not able or willing to return for this appointment for the 2nd visit you cannot choose this method to terminate this pregnancy.

15. By sighing below I understand if I do not keep my follow up appointment I will be mailed a certified letter from South Women’s Services to remind me to return for an appointment.

16. I realize I have the opportunity to discuss this procedure with a physician at South Avenue Women’s Services and I waive this right because I feel I have been adequately informed about the procedure I have selected.

Patients Signature: Date:
Patients Name (Print):

The patient signed the PATIENT CONSENT in my presence after she was counseled and her questions were answered. I have given her the Medication Guide & a coy of the consent form for Mifeprex.

Provider’s Signature:

Name of Provider: Roger M. Olander MD
Marion Olander, RPAC/Director of Clinical Services